Drugs to improve synaptic transmission
US6710073B1 · kind B1 · utility
0Cited by
2References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 2, 1996 |
| Grant date | Mar 23, 2004 |
| Priority date | — |
| Expiry date | Dec 2, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D313/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Peripherally administered analogs and derivatives of Brefeldin A are used to enhance learning and reverse memory dysfunction through induced long term potentiation in hippocampal tissues.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.